From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
Grade
1
2
3
4
n
%
Pulmonary embolism
-
1.9
Cardiac ischaemia
Epistaxis
7.6
Gastrointestinal bleeding
Hypertension
5
9.5
3.8
Proteinuria
7
13.2